Member Info for Sangijuelas1

I am happy to discuss legitimate criticisms of the company and debate with someone who presents some evidence for their opinion.
But when someone just states their opinions about what they think should have happened or what they think is wrong with the company with no EVIDENCE to back up other than a deflated share price I won't bother.
The other day we had AlexLSE claiming that 4D is the same as Evelo. When I asked him for some evidence after presenting some of the key differences he hasn't been back since.
Yesterday it was a guy saying he had sold out because some Israeli scientists had cured cancer and 4D had been too slow and also their cancer results were rubbish.

For anyone who is interested it is necessary to register to get through to the webinar

Duncan "We have generated data which we think will lead to the first live biotherapeutic immunotherapy treatment for cancer"

Off work sick today. Gonna stick on the SITC presentation as was taking a closer look at some of the slides last night, which showed the potency of the immune response and the proliferation of cancer killing cells following dosing with MRX 0518.

It's going to Uranus!

Just filter it

Because cretins deserve to be called out.

He came out with his scare story about Israeli scientists curing cancer and claiming that 4D missed the boat.

https://www.investors.com/news/technology/microbiome-medicines-biotech-companies-big-pharma-new-treatments/

Chardan's Feehley is bullish on the microbiome space. She expects microbiome drugs in the future to be as important as gene therapy is today. Big Pharma investments over the last six years have served to legitimize the space, she said.
We see the big biopharma interest in the microbiome as a validator of the market potential of the space," she said. "Even if microbiome medicines only capture a fraction of the available market in inflammatory bowel disease, the segment could still be a blockbuster opportunity.

https://www.statnews.com/2020/11/20/multiple-sclerosis-gut-microbiome-link/

You are absolute pond life. 4D are helping to extend the lives of some of the sickest people in our society with stage 4 cancer. And here are you calling it a dog with fleas. Get-tofuk

A lot of companies are working to beat cancer. The Israeli scientists you mention are doing experiments in mice and hope to trial their cancer cell killing therapy in humans in a couple of years time.
4D are dosing multiple extremely sick patients with MRX 0518 today and presenting highly efficacious results, which is the reason they are going to meet with the FDA in Q1 next year.

All the energy you guys spend on here could really be put to much better use in the world.
Never have so many words said so little.
The majority of you have gone psychotic waking up every day looking for the RNS. It's like the struggles of Tantalus, always reaching for the fruit and never quite reaching it.

Before Thanksgiving

Will probably be thin trading day in US tomorrow as day b

At the troll farm?
Or maybe just bots.

For anyone who subscribes otherwise paywall

https://www.telegraph.co.uk/science/2019/05/20/biotherapeutics-new-era-cures-cancer-parkinsons-horizon-using/

The reason they bought Katrin Rupalla on as non exec director was for her experience in bringing novel drugs to market

"Throughout her career, she has led regional and global teams responsible for obtaining approvals for multiple new therapeutics and indications, including Opdivo®, Yervoy®, Rituxan®, Xeloda®, Avastin ®, Revlimid® and Vidaza®, among others."

Forgot vaccines. Developing 3 indications with MSD with potential milestone payments of 350m each plus share of future royalties.

Multiple shots on goal

1)Partner with another pharma to get Blautix through Phase 3 and bring to market. Multi billion market with serious unmet need.
2) Continue trial of MRX 0518, collecting further efficacy and safety data, so as to meet with FDA in Q1 for a priority review of combo with Keytruda. Possible fast track authorisation.
3) Resume trials with Asthma drug Mrx4DP 0004 - multi billion pound market with significant unmet need.
4) Use increased funding from US investors to further explore the monetization of the Micro RX platform by identifying new novel candidates.
5) Explore other partnerships with makers of Immune Checkpoint Inhibitors for other tumours.
6) Take 2 drugs into clinic for neuro degenerative illnesses such as Parkinsons.

This might sound like a lot to do but the worst type of pharma is a one track pony.

It seems some here would like to skip approval and have Duncan flogging stuff from a suitcase in Rotherham market.

DYOR
No one here is your Joe Boy